Clinical Trials Browser

Phase 2 × INDUSTRY × remestemcel-l × Clear all

NCT00136903 2022-01-31

Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

Phase 2 Completed

LymphoidOther hematologic neoplasm

Graft vs Host Disease, Leukemia, Lymphoma